Centex Studies-LC Works With Regeneron on Potential COVID-19 Treatment

Machelle Stephens

October 13, 2020 LAKE CHARLES, LA – Regeneron Pharmaceuticals, Inc. is conducting research involving their antibody cocktail, REGN-COV2 in non-hospitalized COVID-19 patients. Centex Studies-Lake Charles is proud to announce that they are one of a limited number of research sites working with Regeneron on this project. 

“We are so proud to have the honor of working with Regeneron on something so important and relevant to our community,” said Dr. Michael Seep, Principal Investigator at Centex Studies-Lake Charles. 

Over 2,000 people have enrolled in the REGN-COV2 studies across the nation, but we’re not done yet! Another critical component in getting this potential treatment to the public is making sure every part of the population is represented. Diversity is a primary factor in all research, but the fact that COVID-19 is a worldwide pandemic makes it that much more important.  

“Our community has a part to play in beating this thing. We still need volunteers. After all that our community has been through, we have to stand together!” Said Dr. Seep.  

Those who wish to get involved in the Regeneron REGN-COV2 study or other COVID studies at Centex Studies-Lake Charles can call 337-433-3441 or visit www.centexstudies.com for more information.  

About Centex Studies  

Centex Studies is a multi-specialty research organization with three locations across Texas and Louisiana. Research studies evaluating potential new options for several indications are enrolling now. There is no cost to participate, and compensation for study-related time and travel may be available. 


Leave a Comment

Machelle Stephens

Before Full FDA Approval is Received, More Research is still Needed!

Centex Studies – Lake Charles still needs volunteers to help find the best and most effective...

Read more
Machelle Stephens

Still Work to Be Done Before FDA Approves COVID Vaccine

Centex Studies – Houston still needs volunteers to help find the best and most effective vaccine. 


Read more